Intellipharmaceutics International Alpha and Beta Analysis
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Intellipharmaceutics International. It also helps investors analyze the systematic and unsystematic risks associated with investing in Intellipharmaceutics over a specified time horizon. Remember, high Intellipharmaceutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Intellipharmaceutics' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Intellipharmaceutics |
Intellipharmaceutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Intellipharmaceutics market risk premium is the additional return an investor will receive from holding Intellipharmaceutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Intellipharmaceutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Intellipharmaceutics' performance over market.| α | 0.00 | β | 0.00 |
Intellipharmaceutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Intellipharmaceutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Intellipharmaceutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Intellipharmaceutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Intellipharmaceutics. Please utilize our Beneish M Score to check the likelihood of Intellipharmaceutics' management manipulating its earnings.
| 4th of June 2024 Upcoming Quarterly Report | View | |
| 30th of November 2023 Next Fiscal Quarter End | View |
Build Portfolio with Intellipharmaceutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |